Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!
Regulators said that there were no risk-free doses of Epogen, Aranesp and Procrit and that doctors should use the medicines only in patients suffering from severe anemia.
By NICHOLAS CONFESSORE and DANNY HAKIM 25 Jun, 2011--
Source: http://feeds.nytimes.com/click.phdo?i=e92d965ae1a7ddf10ba86d686a26a18e
~
Manage subscription | Powered by rssforward.com